Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Surmodics's share price for the quarter that ended in Jun. 2025 was $29.71. Surmodics's Shares Outstanding (EOP) for the quarter that ended in Jun. 2025 was 14.3 Mil. Therefore, Surmodics's market cap for the quarter that ended in Jun. 2025 was $424.8 Mil.
Surmodics's quarterly market cap
declined
from Dec. 2024 ($566.0 Mil) to Mar. 2025 ($436.5 Mil) and
declined
from Mar. 2025 ($436.5 Mil) to Jun. 2025 ($424.8 Mil).
Surmodics's annual market cap
increased
from Sep. 2022 ($426.5 Mil) to Sep. 2023 ($454.2 Mil) and
increased
from Sep. 2023 ($454.2 Mil) to Sep. 2024 ($555.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Surmodics's Enterprise Value for Today is $614.4 Mil.
Surmodics (NAS:SRDX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Surmodics Market Cap Related Terms
Surmodics Market Cap Historical Data
* Premium members only.
The historical data trend for Surmodics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Surmodics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surmodics Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surmodics's Market Cap distribution charts can be found below:
* The bar in red indicates where Surmodics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Surmodics's Market Cap for the fiscal year that ended in Sep. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surmodics (SRDX) has a Market Cap of $614.5 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Surmodics and its competitors.
Is Surmodics' Market Cap too high?
Surmodics' current Market Cap is $614.5 Mil. The Medical Devices & Instruments industry median Market Cap is 122.56. Surmodics' value of $614.5 Mil is 401.4% above this industry median. Overall, Surmodics has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Surmodics' Market Cap compare to CBLL and OFIX?
Surmodics' Market Cap of $614.5 Mil can be compared against companies in the Medical Devices & Instruments industry. The industry median Market Cap is 122.56. Surmodics' value of $614.5 Mil is 401.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.56, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surmodics's current Market Cap of $614.5 Mil is 401.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Surmodics and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surmodics's current Market Cap is $614.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surmodics stock overvalued right now?
Surmodics (SRDX) has a current Market Cap of $614.5 Mil. The stock's GF Value™ is $32.10, compared to a current price of $42.98 — trading 33.9% above its estimated fair value. The current Market Cap is $614.5 Mil and 401.4% above the Medical Devices & Instruments industry median of 122.56. Surmodics' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Surmodics (SRDX), the current Market Cap is $614.5 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surmodics (SRDX) Overvalued in 2026?
Based on GuruFocus' analysis, Surmodics stock appears to be overvalued.
The current stock price of $42.98 is trading 33.9% above its estimated GF Value™ of $32.10.
Key valuation signals for SRDX:
Market Cap: $614.5 Mil
GF Value™: $32.10 vs. price of $42.98 (33.9% above fair value)
Industry Position: 401.4% above the Medical Devices & Instruments median
No single metric tells the full story. See the SRDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
51GF Score
Get the complete analysis for SRDX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRDX has been successfully added to your 
